GFAP and Alzheimer disease: Compared with the CTL group, the AD and ADT groups expressed significantly more GFAP (Figure 7B, AD: DG, F(1,62) = 93.209, P < 0.001; CA2-3, F(1,62) = 38.885, P < 0.001; CA1, F(1,62) = 98.137, P < 0.001; ADT: DG, F(1,62) = 4.284, P = 0.043; CA2-3, F(1,62) = 4.591, P = 0.036; CA1, F(1,62) = 4.216, P = 0.044), but the difference between the AD group and CTL group was more significant than that between the ADT group and CTL group.